Virtu Financial’s Definium Therapeutics DFTX Stock Holding History

Virtu Financial’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$273K	Buy	+14,460	New	+$245K	0.01%	861
2025 Q4	–	Sell	-32,184	Closed	-$379K	–	2015
2025 Q3	$379K	Buy	+32,184	New	+$300K	0.02%	661
2025 Q2	–	Sell	-32,836	Closed	-$192K	–	1817
2025 Q1	$192K	Buy	+32,836	New	+$235K	0.01%	825
2024 Q2	–	Sell	-25,440	Closed	-$239K	–	1669
2024 Q1	$239K	Buy	+25,440	New	+$145K	0.02%	706
2023 Q4	–	Sell	-28,494	Closed	-$89K	–	1846
2023 Q3	$89K	Buy	+28,494	New	+$117K	0.01%	843
2023 Q1	–	Sell	-70,157	Closed	-$154K	–	1854
2022 Q4	$154K	Buy	70,157 +34,247	+95%	+$95.1K	0.02%	805
2022 Q3	$126K	Buy	+35,910	New	+$345K	0.01%	1024
2022 Q2	–	Sell	-1,736	Closed	-$29K	–	1880
2022 Q1	$29K	Buy	+1,736	New	+$30.1K	﹤0.01%	1243
2021 Q4	–	Sell	-2,490	Closed	-$87K	–	2000
2021 Q3	$87K	Sell	2,490 -13,037	-84%	-$564K	0.01%	1181
2021 Q2	$804K	Buy	+15,527	New	+$815K	0.08%	281

Other funds holding DFTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Virtu Financial's DFTX Position: Q1 2026 in Review

Virtu Financial opened a new position in Definium Therapeutics (DFTX) in Q1 2026: 14,460 shares worth $273K. The stake represents 0.01% of the portfolio and ranks #861 among its holdings. This is a return to the name: Virtu Financial previously reported a position in DFTX as recently as Q3 2025.

Virtu Financial first reported a position in DFTX in Q2 2021 and has held it in 10 quarters since. The position peaked at $804K in Q2 2021. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

Virtu Financial held 14,460 shares of Definium Therapeutics worth $273K as of Q1 2026.
Definium Therapeutics was a new Virtu Financial position in Q1 2026.
Definium Therapeutics made up 0.01% of Virtu Financial's portfolio in Q1 2026, its #861 holding.
Virtu Financial first reported a position in Definium Therapeutics in Q2 2021 and has held it in 10 quarters since.
Virtu Financial's Definium Therapeutics position peaked at $804K in Q2 2021.
247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.